GLP1: The First Decade

GLP-1 Receptor agonists (GLP-1 RAs) are a widely recommended class of glucose-lowering agents in type 2 diabetes. The best representatives of this class are capable of lowering plasma glucose with an efficacy approaching that of insulin regimens, but with a lower risk of hypoglycaemia and the added benefit of weight loss. Their ability to prevent cardiovascular events in high-risk clients has re-emphasised the particular benefits of GLP-1 RAs in the therapy of type 2 diabetes.

Novel, yet ‘off-label’ potential uses for GLP-1 RAs outside type 2 diabetes, such as their use in people with type 1 diabetes with additional metabolic risks, in neurodegenerative diseases, and in psoriasis, are also being explored.

Gather your thoughts and experiences around using the GLP-1 receptor agonist class of medications in your clinical practice and tune in to this thought-provoking session!